Hepion Pharmaceuticals, Inc(NASDAQ:HEPA) 
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways inv...
Website: http://contravir.com/
Founded: 2013
Full Time Employees: 12
CEO: Robert Foster
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.46
H 0.47
L 0.42
C 0.46
V 1,040,634
10EMA 0.46
20EMA 0.46
60EMA 0.46
120EMA 0.46
250EMA 0.46